Page 1 of Clinical Trials for ( Spectrum Pharmaceuticals AND Inc ) [SPONSOR-COLLABORATORS], 27 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Phase 3 Trial of Single-Dose Intravesical EOquin® as a Surgical Adjuvant for Noninvasive Bladder Cancer
Last Updated: March 11, 2011
Condition(s): Bladder Cancer
2
Terminated
Phase 3 Study of Zevalin Following R-CVP in Previously Untreated Patients With Follicular NHL
Last Updated: March 7, 2011
Condition(s): Follicular Lymphoma; Lymphoma, Follicular
3
Completed
The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate
Last Updated: January 12, 2009
Condition(s): Benign Prostatic Hypertrophy
4
Recruiting
Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC)
Last Updated: May 10, 2012
Condition(s): Bladder Cancer
5
Recruiting
A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies
Last Updated: January 6, 2012
Condition(s): Solid Tumor; Hematological Malignancy
6
Active, not recruiting
Phase II Trial of EOquin in High-Risk Superficial Bladder Cancer
Last Updated: April 17, 2007
Condition(s): Bladder Neoplasms
7
Recruiting
Maximum Tolerated Dose Study of Belinostat (PXD-101)in Combination With Paclitaxel Plus Carboplatin in Chemotherapy-Naive Patients With Stage IV Non-Small-Cell Lung Cancer (NSCLC)
Last Updated: May 10, 2012
Condition(s): Stage IV Non-small Cell Lung Cancer
8
Recruiting
Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)
Last Updated: April 27, 2012
Condition(s): Glioblastoma Multiforme
9
Recruiting
Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer
Last Updated: April 18, 2012
Condition(s): Bladder Cancer
10
Active, not recruiting
Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
Last Updated: January 6, 2012
Condition(s): Peripheral T-cell Lymphoma
11
Not yet recruiting
Phase I Mass Balance, PK and Safety Study of 14C-Labeled Belinostat in Patients With Advanced Cancer
Last Updated: April 25, 2012
Condition(s): Advanced Cancer
12
Terminated
Trial of the Safety and Efficacy of Ozarelix in Patients With Benign Prostatic Hyperplasia (BPH)
Last Updated: February 2, 2010
Condition(s): Benign Prostatic Hyperplasia (BPH)
13
Recruiting
Study of Zevalin Versus Observation in Patients at Least 60 Yrs Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in PET-negative Complete Remission After R-CHOP or R-CHOP-like Therapy
Last Updated: April 25, 2012
Condition(s): Diffuse Large B-cell Lymphoma; Follicle Center Lymphoma
14
Recruiting
Study to Assess the Safety and the Phosphate Binding Capacity of Renazorb
Last Updated: April 16, 2012
Condition(s): Safety; Phosphate Binding Capacity
15
Recruiting
Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma
Last Updated: April 16, 2012
Condition(s): Non-Hodgkin's Lymphoma
16
Completed
Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma
Last Updated: January 8, 2008
Condition(s): Mantle Cell Lymphoma; Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
17
Active, not recruiting
Trial of Single-Dose Intravesical EOquin® as a Surgical Adjuvant Instilled in the Early Postoperative Period in Patients Undergoing TUR-BT
Last Updated: August 2, 2011
Condition(s): Bladder Cancer
18
Completed
A Phase I, Open-label, Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Endothelin B Agonist, SPI-1620, in Patients With Recurrent or Progressive Carcinoma
Last Updated: April 16, 2012
Condition(s): Carcinoma
19
Active, not recruiting
International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer
Last Updated: April 25, 2012
Condition(s): Prostate Cancer
20
Recruiting
Study of PXD101 and Doxorubicin to Treat Soft Tissue Sarcomas
Last Updated: June 15, 2011
Condition(s): Soft Tissue Sarcomas

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Spectrum+Pharmaceuticals%2C+Inc

Page 1 of Clinical Trials for ( Spectrum Pharmaceuticals AND Inc ) [SPONSOR-COLLABORATORS], 27 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About